From the Guidelines
The treatment for cardiovascular disease typically involves a combination of lifestyle modifications and medications, with the goal of reducing morbidity, mortality, and improving quality of life. The most recent and highest quality study, 1, recommends adopting a healthy and balanced diet, such as the Mediterranean or DASH diets, to help reduce blood pressure and cardiovascular disease risk.
- Lifestyle changes include:
- Adopting a heart-healthy diet low in saturated fats and sodium
- Regular physical activity, aiming for at least 150 minutes of moderate exercise weekly
- Maintaining a healthy weight
- Quitting smoking
- Limiting alcohol consumption to less than 100 g/week of pure alcohol
- Common medications include:
- Antihypertensives such as ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), or dihydropyridine CCBs (e.g., amlodipine) to control blood pressure
- Statins (e.g., atorvastatin) to lower cholesterol
- Antiplatelet drugs like aspirin to prevent blood clots
- Beta-blockers (e.g., metoprolol) for heart rate control and to reduce the risk of cardiovascular events It is recommended to initiate combination blood pressure-lowering treatment for most patients with confirmed hypertension as initial therapy, with preferred combinations including a RAS blocker with a dihydropyridine CCB or diuretic 1. Treatment plans must be individualized based on the specific type of cardiovascular disease, its severity, and patient factors. These interventions work by addressing the underlying causes of cardiovascular disease: reducing atherosclerotic plaque formation, improving blood flow, decreasing cardiac workload, and preventing complications like heart attacks and strokes. In patients with elevated blood pressure and low/medium cardiovascular risk, lifestyle measures are recommended to reduce the risk of cardiovascular disease 1. In patients with elevated blood pressure and sufficiently high cardiovascular risk, pharmacological treatment is recommended after 3 months of lifestyle intervention, with a goal of reducing blood pressure to <130/80 mmHg 1. It is also recommended to maintain blood pressure-lowering drug treatment lifelong, even beyond the age of 85 years, if well tolerated 1.
From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
Definition of Hemoarica
There is no direct information available on "hemoarica" in the provided studies.
Treatment for Cardiovascular Disease
- The treatment for cardiovascular disease involves managing hypertension, hyperlipidemia, and other metabolic abnormalities 2, 3, 4, 5, 6.
- Alternative step I antihypertensive agents such as alpha 1-blockers, ACE inhibitors, and calcium channel blockers can be used to manage hypertension without interfering with lipid therapy 2.
- ACE inhibitors and angiotensin receptor blockers (ARBs) are recommended for patients with hypertension and metabolic syndrome, as they reduce the odds of developing new onset type 2 diabetes and decrease albuminuria 4.
- Lipid therapy should be aggressive to attenuate the medical complications of essential hypertension 3.
- A multi-targeted, integrated therapeutic approach is required to simultaneously treat high blood pressure, obesity, lipid disorders, and type 2 diabetes (if present) in patients with metabolic syndrome 4.
- Statins, ACE inhibitors, and ARBs are effective in reducing cardiovascular disease, and their therapeutic evidence is updated in recent clinical trials 6.